0002140719-26-000001.txt : 20260723 0002140719-26-000001.hdr.sgml : 20260723 20260723141140 ACCESSION NUMBER: 0002140719-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260723 DATE AS OF CHANGE: 20260723 EFFECTIVENESS DATE: 20260723 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioGene Therapeutics Inc. CENTRAL INDEX KEY: 0002140719 ORGANIZATION NAME: EIN: 352875404 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-591997 FILM NUMBER: 261196547 BUSINESS ADDRESS: STREET 1: 5900 BALCONES DR, STE 100 CITY: AUSTIN STATE: TX ZIP: 78731 BUSINESS PHONE: 1-512-379-7526 MAIL ADDRESS: STREET 1: 5900 BALCONES DR, STE 100 CITY: AUSTIN STATE: TX ZIP: 78731 D 1 primary_doc.xml X0708 D LIVE 0002140719 BioGene Therapeutics Inc. 5900 BALCONES DR, STE 100 AUSTIN TX TEXAS 78731 1-512-379-7526 TEXAS None None Corporation true 2024 STEPHEN VAN DEVENTER 5900 BALCONES DR, STE 100 AUSTIN TX TEXAS 78731 Executive Officer Director DEEPAK SAMPATH 5900 BALCONES DR, STE 100 AUSTIN TX TEXAS 78731 Director PATROSKI LAWSON 5900 BALCONES DR, STE 100 AUSTIN TX TEXAS 78731 Director STEVE GLOVER 5900 BALCONES DR, STE 100 AUSTIN TX TEXAS 78731 Director RAJ PRUTHI 5900 BALCONES DR, STE 100 AUSTIN TX TEXAS 78731 Director DAVID TYRONNE HOWTON 5900 BALCONES DR, STE 100 AUSTIN TX TEXAS 78731 Director Biotechnology Decline to Disclose 06b false 2025-04-01 false true true false 0 4550000 4550000 0 Consists of the grant of 310,000 stock options and the grant of 600,000 restricted share units and the underlying shares. false 6 0 0 0 false BioGene Therapeutics Inc. /s/ Stephen Van Deventer Stephen Van Deventer CEO 2026-07-23